Asplenia primary prevention: Difference between revisions

Jump to navigation Jump to search
Line 30: Line 30:
**All [[age-appropriate]] [[vaccines]] and the yearly [[influenzae]] [[vaccine]] should be given to [[household]] contacts of [[asplenic patients]].
**All [[age-appropriate]] [[vaccines]] and the yearly [[influenzae]] [[vaccine]] should be given to [[household]] contacts of [[asplenic patients]].
**Before [[splenectomy]] and after the [[surgical removal]], [[vaccinations]] are also recommended.<ref name="pmid26130882">{{cite journal| author=Huebner ML, Milota KA| title=Asplenia and fever. | journal=Proc (Bayl Univ Med Cent) | year= 2015 | volume= 28 | issue= 3 | pages= 340-1 | pmid=26130882 | doi=10.1080/08998280.2015.11929267 | pmc=4462215 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26130882  }} </ref>
**Before [[splenectomy]] and after the [[surgical removal]], [[vaccinations]] are also recommended.<ref name="pmid26130882">{{cite journal| author=Huebner ML, Milota KA| title=Asplenia and fever. | journal=Proc (Bayl Univ Med Cent) | year= 2015 | volume= 28 | issue= 3 | pages= 340-1 | pmid=26130882 | doi=10.1080/08998280.2015.11929267 | pmc=4462215 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26130882  }} </ref>
**[[Patient]] with [[functional asplenia]] or [[autosplenectomy]], it is also advised to continue [[aggressive]] [[vaccination]] [[schedules]]. Recommended vaccinations in these patients are the [[pneumococcal conjugate vaccine]] (PCV-13) 8 weeks in advance, as well as the [[pneumococcal polysaccharide vaccine]] (PPSV-23), [[Haemophilus influenzae type B]] vaccine (Hib), and the [[quadrivalent]] [[meningococcal conjugate]] [[vaccine]] before [[14 days]] of [[planned surgery]] for [[splenectomy]].  
**[[Patient]] with [[functional asplenia]] or [[autosplenectomy]], it is also advised to continue [[aggressive]] [[vaccination]] [[schedules]]. Recommended vaccinations in these patients are the [[pneumococcal conjugate vaccine]] (PCV-13) 8 weeks in advance, as well as the [[pneumococcal polysaccharide vaccine]] (PPSV-23), [[Haemophilus influenzae type B]] vaccine (Hib), and the [[quadrivalent]] [[meningococcal conjugate]] [[vaccine]] before [[14 days]] of [[planned surgery]] for [[splenectomy]].
*'''Revaccination''': In [[asplenia]] or [[splenic dysfunction]] patients [[antibody levels]] are likely to decline rapidly therefore [[revaccination]] with 23-valent PPV is recommended [[every five years]]. There is no required for testing of antibodies prior to vaccination.


==Antibiotic prophylaxis==
==Antibiotic prophylaxis==

Revision as of 10:54, 20 July 2021

Asplenia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Asplenia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Asplenia primary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Asplenia primary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Asplenia primary prevention

CDC on Asplenia primary prevention

Asplenia primary prevention in the news

Blogs on Asplenia primary prevention

Directions to Hospitals Treating Asplenia

Risk calculators and risk factors for Asplenia primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Anum Dilip, M.B.B.S[2]

Overview

There are no established measures for the primary prevention of [disease name].

OR

There are no available vaccines against [disease name].

OR

Effective measures for the primary prevention of [disease name] include [measure1], [measure2], and [measure3].

OR

[Vaccine name] vaccine is recommended for [patient population] to prevent [disease name]. Other primary prevention strategies include [strategy 1], [strategy 2], and [strategy 3].

Primary Prevention

Vaccination

Antibiotic prophylaxis

  • For children

References

  1. Waghorn DJ (2001). "Overwhelming infection in asplenic patients: current best practice preventive measures are not being followed". J Clin Pathol. 54 (3): 214–8. doi:10.1136/jcp.54.3.214. PMC 1731383. PMID 11253134.
  2. Salvadori MI, Price VE, Canadian Paediatric Society, Infectious Diseases and Immunization Committee (2014). "Preventing and treating infections in children with asplenia or hyposplenia". Paediatr Child Health. 19 (5): 271–8. PMC 4029242. PMID 24855431.
  3. Huebner ML, Milota KA (2015). "Asplenia and fever". Proc (Bayl Univ Med Cent). 28 (3): 340–1. doi:10.1080/08998280.2015.11929267. PMC 4462215. PMID 26130882.

Template:WH Template:WS